Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × Hydromorphone × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Paclitaxel 221 Carboplatin 218 Gemcitabine 203 Docetaxel 188 Cisplatin 187 Bevacizumab 185 pembrolizumab 182 Pemetrexed 132 Capecitabine 124 Fluorouracil 106 Cyclophosphamide 102 Oxaliplatin 99 Nivolumab 90 Dexamethasone 79 Leucovorin 75 Rituximab 71 Trastuzumab 70 Irinotecan 70 Cetuximab 65 Injections 64 Prednisone 60 Ipilimumab 58 Doxorubicin 56 atezolizumab 55 Erlotinib Hydrochloride 55 Temozolomide 54 Bortezomib 54 Radiotherapy 51 Drug Therapy 47 Fulvestrant 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03564548 2021-07-28

REBORN

Tetra Bio-Pharma

Phase 2 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡